Join
Live feed
·
INSIDERFilingvia Quantisnow
Elicio Therapeutics Inc. logo

CEO, President and Director Connelly Robert was granted 73,600 shares, increasing direct ownership by 157% to 120,570 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ELTX· Elicio Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELTX (Elicio Therapeutics Inc.) and more on Quantisnow.